Spruce Biosciences Inc expected to post a loss of 57 cents a share - Earnings Preview

Spruce Biosciences

12/11/2021 13:17

* Spruce Biosciences Inc  SPRB.OQ   SPRB.O  is expected to show
no change in quarterly revenue when it reports  results on
November 16 (estimated). 
​* Refinitiv's mean analyst estimate for Spruce Biosciences Inc
is for a loss of 57 cents per share. For the same quarter last
year, the company reported a loss of $12.35 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Spruce
Biosciences Inc is $26​, about 83.1% above​ its last closing
price of $4.40. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2021  -0.45       -0.45      -0.50     Missed  -11.1
 Mar. 31 2021  -0.42       -0.42      -0.42     Met     0.8
 Dec. 31 2020              -0.59      -0.39     Beat    34.4​
 Sep. 30 2020  -0.51       -0.51      -12.35    Missed  -2,321
                                                        .6
 ​​                                                     
                                                        ​
 This summary was machine generated November 12 at 13:17 GMT. 
All figures in US dollars  unless otherwise stated